Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Wheeler

Showing results (61-70 of 175) with videos related to

Pageof 18
Sort By:
Molecular and Cellular Biology|April 16, 2005
Orphan nuclear receptor LRH-1 is required to maintain Oct4 expression at the epiblast stage of embryonic developmentPeili Gu, Bryan Goodwin, Arthur C-K Chung, et al.
European Urology|June 12, 2017
Comprehensive Genomic Characterization of Upper Tract Urothelial CarcinomaTyler J Moss, Yuan Qi, Liu Xi, et al.
JHEP Reports : Innovation in Hepatology|April 11, 2025
CRISPR/Cas9 gene therapy increases the risk of tumorigenesis in the mouse model of hereditary tyrosinemia type ITong Chen, Mercedes Barzi, Nika Furey, et al.
The Journal of Infectious Diseases|January 15, 2004
Once-daily versus twice-daily lopinavir/ritonavir in antiretroviral-naive HIV-positive patients: a 48-week randomized clinical trialJoseph J Eron, Judith Feinberg, Harold A Kessler, et al.
Pediatric Blood & Cancer|October 18, 2016
Renal cell carcinoma harboring somatic TSC2 mutations in a child with methylmalonic acidemiaSamara L Potter, Rajkumar Venkatramani, Scott Wenderfer, et al.
Source Code for Biology and Medicine|June 23, 2016
SV-STAT accurately detects structural variation via alignment to reference-based assembliesCaleb F Davis, Deborah I Ritter, David A Wheeler, et al.
Pediatric Blood & Cancer|September 30, 2014
Initial testing (stage 1) of the PARP inhibitor BMN 673 by the pediatric preclinical testing program: PALB2 mutation predicts exceptional in vivo response to BMN 673Malcolm A Smith, Oliver A Hampton, C Patrick Reynolds, et al.
Nature Genetics|November 10, 2015
Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genesLinghua Wang, Xiao Ni, Kyle R Covington, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|February 6, 2009
Common and rare variants of DAOA in bipolar disorderManjula Maheshwari, Jiajun Shi, Judith A Badner, et al.
BMC Genomics|June 15, 2011
Characterization of single-nucleotide variation in Indian-origin rhesus macaques (Macaca mulatta)Gloria L Fawcett, Muthuswamy Raveendran, David Rio Deiros, et al.
Pageof 18

Showing results (61-70 of 175) with videos related to

Sort By:
Pageof 18
Molecular and Cellular Biology|April 16, 2005
Orphan nuclear receptor LRH-1 is required to maintain Oct4 expression at the epiblast stage of embryonic developmentPeili Gu, Bryan Goodwin, Arthur C-K Chung, et al.
European Urology|June 12, 2017
Comprehensive Genomic Characterization of Upper Tract Urothelial CarcinomaTyler J Moss, Yuan Qi, Liu Xi, et al.
JHEP Reports : Innovation in Hepatology|April 11, 2025
CRISPR/Cas9 gene therapy increases the risk of tumorigenesis in the mouse model of hereditary tyrosinemia type ITong Chen, Mercedes Barzi, Nika Furey, et al.
The Journal of Infectious Diseases|January 15, 2004
Once-daily versus twice-daily lopinavir/ritonavir in antiretroviral-naive HIV-positive patients: a 48-week randomized clinical trialJoseph J Eron, Judith Feinberg, Harold A Kessler, et al.
Pediatric Blood & Cancer|October 18, 2016
Renal cell carcinoma harboring somatic TSC2 mutations in a child with methylmalonic acidemiaSamara L Potter, Rajkumar Venkatramani, Scott Wenderfer, et al.
Source Code for Biology and Medicine|June 23, 2016
SV-STAT accurately detects structural variation via alignment to reference-based assembliesCaleb F Davis, Deborah I Ritter, David A Wheeler, et al.
Pediatric Blood & Cancer|September 30, 2014
Initial testing (stage 1) of the PARP inhibitor BMN 673 by the pediatric preclinical testing program: PALB2 mutation predicts exceptional in vivo response to BMN 673Malcolm A Smith, Oliver A Hampton, C Patrick Reynolds, et al.
Nature Genetics|November 10, 2015
Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genesLinghua Wang, Xiao Ni, Kyle R Covington, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|February 6, 2009
Common and rare variants of DAOA in bipolar disorderManjula Maheshwari, Jiajun Shi, Judith A Badner, et al.
BMC Genomics|June 15, 2011
Characterization of single-nucleotide variation in Indian-origin rhesus macaques (Macaca mulatta)Gloria L Fawcett, Muthuswamy Raveendran, David Rio Deiros, et al.
Pageof 18